investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Systematic identification of resistance mechanisms to HER2-targeted therapies in breast cancer.
Che-Wei Chang
0 Collaborator(s)
Funding source
Canadian Institutes of Health Research (CIHR)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Che-Wei Chang
Ontario Institute for Cancer Research
Toronto, Canada
Related projects
Dana Pe'Er
Integrative Cancer Genomics: Drivers, Pathways and Drugs
Breast
David H Haussler
Center for Big Data in Translational Genomics
Breast
Thomas Westbrook
Discovering Genetic Networks of Triple-Negative Breast Cancer
Breast
Kevin Bennewith
Promotion of breast cancer metastasis by tumour hypoxia and myeloid cells
Breast
Richard A Anderson
PI Signaling Role in Epithelial/Mesenchymal Transition
Breast
Marcel Bally
Identifying Cytoprotective Responses Triggered Following Initial Exposure to Targeted Therapy: Defining Improved Treatment Strategies for Patients with HER-2 Positive Breast Cancer
Breast
Daniel Durocher
Understanding DNA repair pathway choice control
Breast
Hans Schreiber
Immunology of Unique Tumor Specific Antigens
Breast
Shoukat Dedhar
Development of therapeutic antibodies targeting carbonic anhydrase IX (CAIX)
Breast